Exhibit 11.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the use in this Post-Qualification Amendment No. 4 to the Offering Circular of our report dated April 28, 2020 relating to the financial statements of Emerald Health Pharmaceuticals Inc.
/s/ DELOITTE & TOUCHE LLP
San Diego, California
June 15, 2020